Form 8-K - Current report:
SEC Accession No. 0001437749-13-015134
Filing Date
2013-11-21
Accepted
2013-11-21 17:23:32
Documents
1
Period of Report
2013-11-18
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bota20131121_8k.htm 8-K 21378
  Complete submission text file 0001437749-13-015134.txt   22761
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 131236101
SIC: 2836 Biological Products, (No Diagnostic Substances)